Avid Radiopharmaceuticals
Luckens Osias, MBA, currently serves as Manager of Finance and Accounting at Avid Radiopharmaceuticals, overseeing invoice approvals, contract interpretation, and capital management. Prior experience includes an Accountant role at Bracco, where responsibilities involved ensuring the accuracy of financial records for multiple legal entities, and a Staff Accountant position at CareOne Management LLC, focusing on month-end processes and account reconciliations. Additionally, Luckens held roles as Accounts Payable Specialist and Sales Consultant at Sunglass Hut - Luxottica Retail. Luckens holds an MBA from Montclair State University and dual Bachelor's Degrees in Business Administration - Finance and Professional Sales from William Paterson University of New Jersey.
This person is not in any offices
Avid Radiopharmaceuticals
1 followers
At Avid, a wholly owned subsidiary of Eli Lilly and Company, our mission is to develop new molecular imaging agents capable of changing the medical management of significant chronic human diseases. We have assembled an outstanding management team with extensive imaging and CNS development experience to help make pre-symptomatic disease detection a reality. Avid's pipeline of imaging compounds has the potential to dramatically alter the clinical course of challenging conditions such as Alzheimer's disease, Dementia with Lewy Bodies, Parkinson's disease and Diabetes Mellitus. This may be possible because our molecular imaging compounds may be able to detect the first stages of pathological change; allowing early treatment and management of people at risk - perhaps before before symptoms of disease can develop.